Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea
Hae Su Kim, Hee-Jin Kim, Sun-Hee Kim, Joon Young Choi, Young Hyeh Ko, Won Seog Kim, Chul Won Jung, Seok Jin Kim
Korean J Intern Med. 2017;32(5):890-899.   Published online 2017 Aug 18     DOI: https://doi.org/10.3904/kjim.2015.406
Citations to this article as recorded by Crossref logo
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies
Shefali Mehra, Justin Taylor
Cells.2024; 13(3): 243.     CrossRef
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Nathaniel R. Wilson, Marina Konopleva, Arthur E. Frankel, Vikas Gupta, Ruben Mesa, Matthew Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James Mason, Maria Te
Blood.2023; 141(6): 567.     CrossRef
Clinical features, immune profile and induction chemotherapy options for blastic plasmacytoid dendritic cell neoplasm: a systematic review and meta-analysis
Honggang Guo, Mingyue Shi
Future Oncology.2023; 19(7): 531.     CrossRef
Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the Surveillance, Epidemiology, and End Results database
Xiaojing Lin, Li Wang, Qian Hu, Jinbing Zhu, Yali Tao, Li Huang, Ting Niu
European Journal of Haematology.2023; 110(6): 743.     CrossRef
Blastic Plasmacytoid Dendritic Cell Neoplasm
Ayah K. Ali, Mark Russell, Kamran M. Mirza
Advances in Molecular Pathology.2023; 6(1): 15.     CrossRef
Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Nathaniel R. Wilson, Naveen Pemmaraju
Expert Opinion on Pharmacotherapy.2022; 23(4): 431.     CrossRef
Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy
Zehra Narli Ozdemir, Guldane Cengiz Seval, Ugur Sahin, Atilla Uslu, Mehmet Gunduz, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Isinsu Kuzu, Muhit Ozcan, Gunhan Gurman, Osman Ilhan
Indian Journal of Hematology and Blood Transfusion.2021; 37(1): 67.     CrossRef
Blastic plasmacytoid dendritic cell neoplasm of the breast
Hyo-jae Lee, Hye Mi Park, So Yeon Ki, Yoo-Duk Choi, Sook Jung Yun, Hyo Soon Lim
Medicine.2021; 100(19): e25699.     CrossRef
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, Naveen Pemmaraju
Clinical Lymphoma Myeloma and Leukemia.2021; 21(11): 734.     CrossRef
A case report of blastic plasmacytoid dendritic cell neoplasm in a hispanic child
Katy Ordoñez Tanchiva, Pamela Contreras Chavez, Silvana Lucero Loli Guevara, Carlos Rodrigo Quispe Vicuña, Neharika Bhardwaj, Frederick Lansigan, Erik Deconinck
Leukemia Research Reports.2021; 16: 100262.     CrossRef
Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm
Michael Haddadin, Justin Taylor
Hematology/Oncology Clinics of North America.2020; 34(3): 539.     CrossRef
Blastic Plasmacytoid Dendritic Cell Neoplasm
Daniel Kerr, Ling Zhang, Lubomir Sokol
Current Treatment Options in Oncology.2019;[Epub]     CrossRef
Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents
Shunan Wang, Xingtong Wang, Mingsuo Liu, Ou Bai
Annals of Hematology.2018; 97(4): 563.     CrossRef
The advances in therapy of blastic plasmacytoid dendritic cell neoplasm
Daniel Kerr, Lubomir Sokol
Expert Opinion on Investigational Drugs.2018; 27(9): 733.     CrossRef
Ileocecal Mucosal Involvement of Blastic Plasmacytoid Dendritic Cell Neoplasm without Skin Lesions
Hyun Ju Choi, Jongha Park, Jin Lee, Mi Young Kim, Heui Jeong Jeong, Ji Woon Lee, Bomi Kim
The Korean Journal of Medicine.2018; 93(5): 487.     CrossRef